The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis
Open Access
- 26 May 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 14 (8) , 811-822
Abstract
Population-based screening for colorectal cancer is an effective and cost-effective way of reducing colorectal cancer incidence and mortality. Many genetic and phenotypic risk factors for colorectal cancer have been identified, leading to development of colorectal cancer risk scores with varying discrimination. However, these are not currently used by population screening programs. We performed an economic analysis to assess the cost-effectiveness, clinical outcomes, and resource impact of using risk-stratification based on phenotypic and genetic risk, taking a UK National Health Service perspective. Biennial fecal immunochemical test (FIT), starting at an age determined through risk-assessment at age 40, was compared with FIT screening starting at a fixed age for all individuals. Compared with inviting everyone from age 60, using a risk score with area under the receiver operating characteristic curve of 0.721 to determine FIT screening start age, produces 418 QALYs, costs £247,000, and results in 218 fewer colorectal cancer cases and 156 fewer colorectal cancer deaths per 100,000 people, with similar FIT screening invites. There is 96% probability that risk-stratification is cost-effective, with net monetary benefit (based on £20,000 per QALY threshold) estimated at £8.1 million per 100,000 people. The maximum that could be spent on risk-assessment and still be cost-effective is £114 per person. Lower benefits are produced with lower discrimination risk scores, lower mean screening start age, or higher FIT thresholds. Risk-stratified screening benefits men more than women. Using risk to determine FIT screening start age could improve the clinical outcomes and cost effectiveness of colorectal cancer screening without using significant additional screening resources. Prevention Relevance: Colorectal cancer screening is essential for early detection and prevention of colorectal cancer, but implementation is often limited by resource constraints. This work shows that risk-stratification using genetic and phenotypic risk could improve the effectiveness and cost-effectiveness of screening programs, without using substantially more screening resources than are currently available.Keywords
All Related Versions
Funding Information
- Bowel Cancer UK (18PG0008)
- UK National Screening Committee (N/A)
- Research England (X/165308-11)
- Cancer Research UK (C55650/A21464)
- Cancer Research UK (C1287/A16563)
This publication has 36 references indexed in Scilit:
- Decomposing socio-economic inequality in colorectal cancer screening uptake in EnglandSocial Science & Medicine, 2015
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old AgePLOS Medicine, 2015
- Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort studyBMJ Open, 2015
- Incidence of Colorectal Adenomas: Birth Cohort Analysis among 4.3 Million Participants of Screening ColonoscopyCancer Epidemiology, Biomarkers & Prevention, 2014
- Risk factors for adverse events related to polypectomy in the English Bowel Cancer Screening ProgrammeEndoscopy, 2014
- Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in EnglandInternational Journal of Epidemiology, 2011
- Sex, Age, and Birth Cohort Effects in Colorectal NeoplasmsAnnals of Internal Medicine, 2010
- Hereditary and Familial Colon CancerGastroenterology, 2010
- Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)Gut, 2010
- Gender differences in colorectal cancer: implications for age at initiation of screeningBritish Journal of Cancer, 2007